CALIFORNIA: An analysis of 75 edible marijuana products sold to patients in Seattle, San Francisco and Los Angeles found that labels on just 17 percent accurately described their levels of THC, the main psychoactive ingredient, researchers reported Tuesday.
Sixty percent of the products had less THC than their packages advertised, and 23 percent of them had more THC than claimed.
“We need a more accurate picture of what’s being offered to patients,” said Dr. Donald Abrams, the chief of hematology and oncology at San Francisco General Hospital. He was not involved in the new study, which was published in JAMA.
“What we have now in this country is an unregulated medical marijuanaindustry, due to conflicts between state and federal laws,” Dr. Abrams said.